Psychiatry and Neurology, Neurology · Houston, TX
NPI
1477611960
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
6560 Fannin St, Suite 802
Houston, TX, 77030
Phone (713) 441-3780
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
3,036 services
Medicare patients, 2024
337
Average age 72
Drug cost, 2024
$8.5M
2,029 prescriptions
Company payments, 2025
$493
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert G Smith was code 99215 (office e&m - established), 183 times for 118 patients. In total Robert G Smith billed 3,036 services in 35 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 183 | 118 | $136.14 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 163 | 93 | $90.43 | $15K |
| 99222 Hospital E&M - Initial | Facility | 85 | 83 | $97.43 | $8,281 |
| 95886 Electrical Nerve Conductivity | Office | 84 | 30 | $72.96 | $6,129 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 80 | 66 | $12.81 | $1,025 |
| 95886 Electrical Nerve Conductivity | Facility | 60 | 20 | $34.40 | $2,064 |
| 99214 Office E&M - Established | Office | 55 | 47 | $95.58 | $5,257 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 32 | $59.54 | $2,024 |
| 95913 Electrical Nerve Conductivity | Office | 28 | 28 | $220.20 | $6,165 |
| 95913 Electrical Nerve Conductivity | Facility | 16 | 14 | $139.70 | $2,235 |
| 99204 Office E&M - New | Facility | 14 | 14 | $97.84 | $1,370 |
| 99205 Office E&M - New | Office | 13 | 13 | $163.67 | $2,128 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $126.41 | $1,517 |
| 99214 Office E&M - Established | Facility | 12 | 12 | $77.67 | $932 |
| 99221 Hospital E&M - Initial | Facility | 11 | 11 | $66.57 | $732 |
By year: 2022 $127K for 3,401 services; 2023 $118K for 3,799 services; 2024 $97K for 3,036 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert G Smith prescribed most often to Medicare patients was Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50), with 209 prescriptions and refills. In total Robert G Smith wrote 2,029 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 209 | 210 | Under 11 | $2.0M |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 175 | 175 | Under 11 | $1.7M |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 158 | 158 | Under 11 | $1.5M |
| Gabapentin Generic | 130 | 288 | 37 | $3,093 |
| Mycophenolate Mofetil Generic | 78 | 148 | 20 | $7,573 |
| Sodium Chloride 0.9 % Sodium Chloride | 77 | 79 | Under 11 | $643 |
| Pyridostigmine Bromide Generic | 71 | 180 | 24 | $7,585 |
| Tramadol Hcl Generic | 51 | 57 | Under 11 | $532 |
| Duloxetine Hcl Generic | 51 | 89 | 11 | $1,427 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 49 | 49 | Under 11 | $502K |
| Baclofen Generic | 47 | 88 | 15 | $1,667 |
| Diazepam Generic | 31 | 45 | 11 | $365 |
| Levetiracetam Generic | 30 | 48 | Under 11 | $910 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 27 | 29 | Under 11 | $39K |
| Azathioprine Generic | 26 | 58 | Under 11 | $1,551 |
Brand drugs: 861 claims; generic drugs: 1,168 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert G Smith $493 ($493 in general payments such as food, travel and fees) from 10 companies. The largest payer was Genzyme Corporation with $138.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $138 |
| Pfizer Inc. PFE | 6 | $127 |
| Biogen, Inc. BIIB | 2 | $49.21 |
| CSL Behring CSL.AX | 1 | $35.13 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.33 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $32.17 |
| Abbvie Inc. ABBV | 1 | $23.63 |
| Xeris Pharmaceuticals, Inc. | 1 | $20.24 |
| Tanabe Pharma America, Inc. | 1 | $18.18 |
| Averitas Pharma Inc. | 1 | $14.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.